Morgan Stanley Cuts Albemarle Target Price to $161 from $189
Aug 10, 2026
Morgan Stanley reduced its price target for Albemarle Corporation to $161 from $189, indicating a revised valuation outlook for the lithium and chemical producer.
Show all 53 updates